Underwriter

Biotechnology
Company
(Symbol)

Date
Priced

Offering
Price Per
Share

12/31/06
Share
Price

Offering
Gross
(M)

After-Market
Performance
(%)


AG Edwards

BioMimetic Therapeutics Inc. (BMTI) (IPO)

5/12/06

$8

$13.19

$36.8

+65%

Ardour Capital
Investments

Metabolix Inc. (MBLX) (IPO)

11/17/06

$14

$18.94

$109.5

+35%

Banc of America
Securities

Acadia Pharmaceuticals Inc. (ACAD) (co-lead)

4/27/06

$12

$8.79

$59.4

-27%

Acorda Therapeutics Inc. (ACOR) (IPO; lead)

2/10/06

$6

$15.84

$36.5

+150%

Adolor Corp. (ADLR)

2/16/06

$25

$7.52

$143.8

-70%

Alnylam Pharmaceuticals Inc. (ALNY)(co-lead)

1/31/06

$13

$21.40

$66.5

+65%

Alnylam Pharmaceuticals Inc. (ALNY) (lead)

12/12/06

$22

$21.40

$103.4

-3%

Exelixis Inc. (EXEL)

10/5/06

$8.40

$9

$96.6

+7%

Labopharm Inc. (Canada; DDSS) (co-lead)

4/28/06

$8

$5.87

$101.2

-27%

Trubion Pharmaceuticals Inc. (TRBN) (IPO; co-lead)

10/18/06

$13

$18.01

$52

+39%

Valera Pharmaceuticals Inc. (VLRX) (IPO; co-lead)

2/2/06

$9

$8.10

$34.8

-10%

Vanda Pharmaceuticals Inc. (VNDA) (IPO; co-lead)

4/12/06

$10

$24.65

$59.6

+147%

Bear, Stearns & Co.

Alexion Pharmaceuticals Inc. (ALXN)

11/15/06

$43

$40.39

$148.4

-6%

Amylin Pharmaceuticals Inc. (AMLN)

3/30/06

$46.50

$36.07

$534.8

-22%

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Novacea Inc. (NOVC) (IPO; co-lead)

5/10/06

$6.50

$5.66

$44.9

-13%

Brean Murray,
Carret & Co.

Genitope Corp. (GTOP)

2/7/06

$8.50

$3.52

$62.6

-59%

Sirna Therapeutics Inc. (RNAI)

5/24/06

$5

$13**

$51.8

+160%

Canaccord Adams

Acadia Pharmaceuticals Inc. (ACAD)

4/27/06

$12

$8.79

$59.4

-27%

Labopharm Inc. (Canada; DDSS)

4/28/06

$8

$5.87

$101.2

-27%

C.E. Unterberg,
Towbin

Insmed Inc. (INSM) (co-lead)

3/10/06

$2

$0.88

$46

-56%

CIBC World
Markets

Arena Pharmaceuticals Inc. (ARNA) (co-lead)

1/27/06

$16.90

$12.91

$179.8

-24%

Arena Pharmaceuticals Inc. (ARNA) (co-lead)

12/8/06

$13.21

$12.91

$174.7

-2%

Achillion Pharmaceuticals Inc. (ACHN) (IPO; co-lead)

10/26/06

$11.50

$16.11

$59.5

+40%

Indevus Pharmaceuticals Inc. (IDEV)

6/28/06

$4.65

$7.10

$37.43

+53%

MannKind Corp. (MNKD)

12/7/06

$17.42

$16.49

$400.7

-5%

Omrix Bio-pharmaceuticals Inc. (OMRI) (IPO; co-lead)

4/20/06

$10

$30.26

$39.6

+203%

Omrix Bio-pharmaceuticals Inc. (OMRI)

12/15/06

$32

$30.26

$48

-5%

SGX Pharmaceuticals Inc. (SGXP) (IPO; co-lead)

1/31/06

$6

$3.50

$24.9

-42%

Sirna Therapeutics Inc. (RNAI)

5/24/06

$5

$13**

$51.8

+160%

Targacept Inc. (TRGT) (IPO)

4/12/06

$9

$9.05

$45

+1%

Citigroup

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Omrix Bio-pharmaceuticals Inc. (OMRI) (co-lead)

12/15/06

$32

$30.26

$48

-5%

Cowen & Co.

Achillion Pharmaceuticals Inc. (ACHN) (IPO; co-lead)

10/26/06

$11.50

$16.11

$59.5

+40%

Acorda Therapeutics Inc. (ACOR) (IPO)

2/10/06

$6

$15.84

$36.5

+150%

Affymax Inc. (AFFY) (IPO)

12/15/06

$25

$34.04

$106.4

+36%

Alexion Pharmaceuticals Inc. (ALXN)

11/15/06

$43

$40.39

$148.4

-6%

Alnylam Pharmaceuticals Inc. (ALNY)

1/31/06

$13

$21.40

$66.5

+65%

Altus Pharmaceuticals Inc. (ALTU) (IPO)

1/26/06

$15

$18.85

$105

+26%

Arena Pharmaceuticals Inc. (ARNA)

1/27/06

$16.90

$12.91

$179.8

-24%

Arena Pharmaceuticals Inc. (ARNA) (co-lead)

12/8/06

$13.21

$12.91

$174.7

-2%

BioMarin Pharmaceutical Inc. (BMRN)

3/24/06

$13

$16.39

$134.6

+26%

Emergent BioSolutions Inc. (NYSE:EBS) (IPO; co-lead)

11/15/06

$12.50

$11.16

$62.6

-11%

Exelixis Inc. (EXEL) (co-lead)

10/5/06

$8.40

$9

$96.6

+7%

Illumina Inc. (ILMN)

5/19/06

$25.50

$39.31

$102.6

+54%

Iomai Corp. (IOMI) (IPO; co-lead)

2/1/06

$7

$4.98

$35

-29%

Kosan Biosciences Inc. (KOSN) (co-lead)

3/30/06

$5

$5.55

$25.5

+11%

Novacea Inc. (NOVC) (IPO; co-lead)

5/10/06

$6.50

$5.66

$44.9

-13%

Replidyne Inc. (RDYN) (IPO)

6/28/06

$10

$5.74

$50

-43%

Credit Suisse
Securities

Alexion Pharmaceuticals Inc. (ALXN)

11/15/06

$43

$40.39

$148.4

-6%

Cell Genesys Inc. (CEGE) (lead)

9/7/06

$4.40

$3.39

$25.3

-23%

Kosan Biosciences Inc. (KOSN) (co-lead)

3/30/06

$5

$5.55

$25.5

+11%

Dawson James
Securities

Biopure Corp. (BPUR) (lead)

12/8/06

$0.64

$0.48

$18.1

-33%

Viragen Inc. (AMEX:VRA) (lead)

10/31/06

$0.26

$0.15

$18.7

-42%

Deutsche Bank
Securities

BioMimetic Therapeutics Inc. (BMTI) (IPO; co-lead)

5/12/06

$8

$13.19

$36.8

+65%

Cadence Pharmaceuticals Inc. (CADX) (IPO; co-lead)

10/25/06

$9

$12.32

$62.1

+37%

Dyax Corp. (DYAX) (lead)

3/9/06

$5.65

$3.03

$31.1

-46%

Nuvelo Inc. (NUVO) (co-lead)

1/31/06

$16

$4

$119.6

-75%

Targacept Inc. (TRGT) (IPO; co-lead)

4/12/06

$9

$9.05

$45

+1%

XenoPort Inc. (XNPT)

6/21/06

$17

$24.55

$76.5

+44%

Dundee Securities

Labopharm Inc. (Canada; DDSS)

4/28/06

$8

$5.87

$101.2

-27%

Ferris, Baker Watts

Immtech International Inc. (AMEX:IMM) (lead)

2/13/06

$8

$7.60

$16

-5%

First Albany Capital

BioMimetic Therapeutics Inc. (BMTI) (IPO)

5/12/06

$8

$13.19

$36.8

+65%

Catalyst Pharmaceutical Partners Inc. (CPRX) (IPO; co-lead)

11/9/06

$6

$4.83

$20.1

-20%

Iomai Corp. (IOMI) (IPO)

2/1/06

$7

$4.98

$35

-29%

Valera Pharmaceuticals Inc. (VLRX) (IPO)

2/2/06

$9

$8.10

$34.8

-10%

Fortis Securities

Arena Pharmaceuticals Inc. (ARNA)

12/8/06

$13.21

$12.91

$174.7

-2%

Valera Pharmaceuticals Inc. (VLRX) (IPO)

2/2/06

$9

$8.10

$34.8

-10%

Friedman Billings Ramsey

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Goldman, Sachs
& Co.

Alexion Pharmaceuticals Inc. (ALXN) (co-lead)

11/15/06

$43

$40.39

$148.4

-6%

Amylin Pharmaceuticals Inc. (AMLN) (co-lead)

3/30/06

$46.50

$36.07

$534.8

-22%

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Exelixis Inc. (EXEL) (co-lead)

10/5/06

$8.40

$9

$96.6

+7%

Illumina Inc. (ILMN) (co-lead)

5/19/06

$25.50

$39.31

$102.6

+54%

Medarex Inc. (MEDX) (co-lead)

4/7/06

$11.75

$14.79

$135.1

+26%

HSBC Securities

Emergent BioSolutions Inc. (NYSE:EBS) (IPO)

11/15/06

$12.50

$11.16

$62.6

-11%

Novacea Inc. (NOVC) (IPO)

5/10/06

$6.50

$5.66

$44.9

-13%

Theravance Inc. (THRX)

2/1/06

$28.50

$30.89

$131.1

+8%

Janney
Montgomery Scott

Medarex Inc. (MEDX)

4/7/06

$11.75

$14.79

$135.1

+26%

Jefferies & Co.

Advanced Magnetics Inc. (AMAG)

12/7/06

$62

$59.72

$130.4

-4%

Metabolix Inc. (MBLX) (IPO)

11/17/06

$14

$18.94

$109.5

+35%

Osiris Therapeutics Inc. (OSIR) (IPO; lead)

8/4/06

$11

$25.32

$38.5

+130%

JMP Securities

Acadia Pharmaceuticals Inc. (ACAD)

4/27/06

$12

$8.79

$59.4

-27%

Achillion Pharmaceuticals Inc. (ACHN) (IPO)

10/26/06

$11.50

$16.11

$59.5

+40%

Alexza Pharmaceuticals Inc. (ALXA) (IPO)

3/8/06

$8

$11.39

$50.6

+42%

Cadence Pharmaceuticals Inc. (CADX) (IPO)

10/25/06

$9

$12.32

$62.1

+37%

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Cerus Corp. (CERS) (co-lead)

3/16/06

$8.75

$5.86

$45.3

-33%

Indevus Pharmaceuticals Inc. (IDEV)

6/28/06

$4.65

$7.10

$37.43

+53%

SGX Pharmaceuticals Inc. (SGXP) (IPO)

1/31/06

$6

$3.50

$24.9

-42%

JP Morgan
Securities

Adolor Corp. (ADLR)

2/16/06

$25

$7.52

$143.8

-70%

Celgene Corp. (CELG) (co-lead)

11/3/06

$51.60

$57.53

$1,032

+11%

Emergent BioSolutions Inc. (NYSE:EBS)(IPO; co-lead)

11/15/06

$12.50

$11.16

$62.6

-11%

MannKind Corp. (MNKD) (co-lead)

12/7/06

$17.42

$16.49

$400.7

-5%

Medarex Inc. (MEDX) (co-lead)

4/7/06

$11.75

$14.79

$135.1

+26%

Nuvelo Inc. (NUVO) (co-lead)

1/31/06

$16

$4

$119.6

-75%

Sirna Therapeutics Inc. (RNAI) (co-lead)

5/24/06

$5

$13**

$51.8

+160%

Vanda Pharmaceuticals Inc. (VNDA)(IPO; co-lead)

4/12/06

$10

$24.65

$59.6

+147%

Lazard Capital
Markets

Acorda Therapeutics Inc. (ACOR) (IPO)

2/10/06

$6

$15.84

$36.5

+150%

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Insmed Inc. (INSM) (co-lead)

3/10/06

$2

$0.88

$46

-56%

Osiris Therapeutics Inc. (OSIR) (IPO)

8/4/06

$11

$25.32

$38.5

+130%

Targacept Inc. (TRGT) (IPO)

4/12/06

$9

$9.05

$45

+1%

Trubion Pharmaceuticals Inc. (TRBN) (IPO)

10/18/06

$13

$18.01

$52

+39%

Leerink Swann & Co.

Arena Pharmaceuticals Inc. (ARNA)

12/8/06

$13.21

$12.91

$174.7

-2%

BioMarin Pharmaceutical Inc. (BMRN)

3/24/06

$13

$16.39

$134.6

+26%

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Indevus Pharmaceuticals Inc. (IDEV)

6/28/06

$4.65

$7.10

$37.43

+53%

Labopharm Inc. (Canada; DDSS)

4/28/06

$8

$5.87

$101.2

-27%

MannKind Corp. (MNKD)

12/7/06

$17.42

$16.49

$400.7

-5%

Omrix Bio-pharmaceuticals Inc. (OMRI) (IPO)

4/20/06

$10

$30.26

$39.6

+203%

Osiris Therapeutics Inc. (OSIR) (IPO)

8/4/06

$11

$25.32

$38.5

+130%

Sirna Therapeutics Inc. (RNAI)

5/24/06

$5

$13**

$51.8

+160%

Lehman Brothers

Acadia Pharmaceuticals Inc. (ACAD) (co-lead)

4/27/06

$12

$8.79

$59.4

-27%

Adolor Corp. (ADLR) (lead)

2/16/06

$25

$7.52

$143.8

-70%

Amylin Pharmaceuticals Inc. (AMLN)

3/30/06

$46.50

$36.07

$534.8

+22%

CV Therapeutics Inc. (CVTX; co-lead)

8/16/06

$9.50

$13.96

$98.3

+47%

Lehman Brothers

Nuvelo Inc. (NUVO)

1/31/06

$16

$4

$119.6

-75%

Tercica Inc. (TRCA) (lead)

1/24/06

$6.40

$5

$36.8

-22%

Merrill Lynch & Co.

Altus Pharmaceuticals Inc. (ALTU) (IPO; co-lead)

1/26/06

$15

$18.85

$105

+26%

BioMarin Pharmaceutical Inc. (BMRN) (lead)

3/24/06

$13

$16.39

$134.6

+26%

Cadence Pharmaceuticals Inc. (CADX) (IPO; co-lead)

10/25/06

$9

$12.32

$62.1

+37%

Celgene Corp. (CELG) (co-lead)

11/3/06

$51.60

$57.53

$1,032

+11%

CV Therapeutics Inc. (CVTX) (co-lead)

8/16/06

$9.50

$13.96

$98.3

+47%

Illumina Inc. (ILMN) (co-lead)

5/19/06

$25.50

$39.31

$102.6

+54%

Labopharm Inc. (Canada; DDSS) (co-lead)

4/28/06

$8

$5.87

$101.2

-27%

MannKind Corp. (MNKD) (co-lead)

12/7/06

$17.42

$16.49

$400.7

-5%

Replidyne Inc. (RDYN) (IPO; co-lead)

6/28/06

$10

$5.74

$50

-43%

Theravance Inc. (THRX) (lead)

2/1/06

$28.50

$30.89

$131.1

+8%

Vertex Pharmaceuticals Inc. (VRTX) (co-lead)

9/14/06

$33

$37.42

$300.3

+13%

Montgomery & Co.

Arena Pharmaceuticals Inc. (ARNA)

1/27/06

$16.90

$12.91

$179.8

-24%

Morgan Joseph
& Co.

Arena Pharmaceuticals Inc. (ARNA)

1/27/06

$16.90

$12.91

$179.8

-24%

Morgan Joseph
& Co.

Arena Pharmaceuticals Inc. (ARNA)

12/8/06

$13.21

$12.91

$174.7

-2%

Morgan Stanley & Co.

Advanced Magnetics Inc. (AMAG) (co-lead)

12/7/06

$62

$59.72

$130.4

-4%

Alexion Pharmaceuticals Inc. (ALXN) (co-lead)

11/15/06

$43

$40.39

$148.4

-6%

Affymax Inc. (AFFY) (IPO; lead)

12/15/06

$25

$34.04

$106.4

+36%

Alnylam Pharmaceuticals Inc. (ALNY) (co-lead)

1/31/06

$13

$21.40

$66.5

+65%

Amylin Pharmaceuticals Inc. (AMLN) (co-lead)

3/30/06

$46.50

$36.07

$534.8

-22%

Altus Pharmaceuticals Inc. (ALTU) (IPO; co-lead)

1/26/06

$15

$18.85

$105

+26%

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Replidyne Inc. (RDYN) (IPO; co-lead)

6/28/06

$10

$5.74

$50

-43%

Trubion Pharmaceuticals Inc. (TRBN) (IPO; co-lead)

10/18/06

$13

$18.01

$52

+39%

Vertex Pharmaceuticals Inc. (VRTX) (co-lead)

9/14/06

$33

$37.42

$300.3

+13%

XenoPort Inc. (XNPT) (lead)

6/21/06

$17

$24.55

$76.5

+44%

Needham & Co.

Arena Pharmaceuticals Inc. (ARNA)

1/27/06

$16.90

$12.91

$179.8

-24%

Arena Pharmaceuticals Inc. (ARNA)

12/8/06

$13.21

$12.91

$174.7

-2%

Oppenheimer & Co.

Arena Pharmaceuticals Inc. (ARNA)

12/8/06

$13.21

$12.91

$174.7

-2%

Omrix Biopharmaceuticals Inc. (OMRI) (IPO)

4/20/06

$10

$30.26

$39.6

+203%

Orion Securities

Labopharm Inc. (Canada; DDSS)

4/28/06

$8

$5.87

$101.2

-27%

Pacific Growth
Equities

Adolor Corp. (ADLR)

2/16/06

$25

$7.52

$143.8

-70%

Alexza Pharmaceuticals Inc. (ALXA) (IPO; co-lead)

3/8/06

$8

$11.39

$50.6

+42%

BioMarin Pharmaceutical Inc. (BMRN)

3/24/06

$13

$16.39

$134.6

+26%

BioMimetic Therapeutics Inc. (BMTI) (IPO; co-lead)

5/12/06

$8

$13.19

$36.8

+65%

Cadence Pharmaceuticals Inc. (CADX) (IPO)

10/25/06

$9

$12.32

$62.1

+37%

Dynavax Technologies Corp. (DVAX) (lead)

10/4/06

$4.40

$9.18

$31.4

+109%

Novacea Inc. (NOVC) (IPO)

5/10/06

$6.50

$5.66

$44.9

-13%

Replidyne Inc. (RDYN) (IPO)

6/28/06

$10

$5.74

$50

-43%

Targacept Inc. (TRGT) (IPO; co-lead)

4/12/06

$9

$9.05

$45

+1%

Trubion Pharmaceuticals Inc. (TRBN) (IPO)

10/18/06

$13

$18.01

$52

+39%

XenoPort Inc. (XNPT)

6/21/06

$17

$24.55

$76.5

+44%

Piper Jaffray & Co.

Acadia Pharmaceuticals Inc. (ACAD)

4/27/06

$12

$8.79

$59.4

-27%

Piper Jaffray & Co.

Acorda Therapeutics Inc. (ACOR) (IPO)

2/10/06

$6

$15.84

$36.5

+150%

Alexion Pharmaceuticals Inc. (ALXN)

11/15/06

$43

$40.39

$148.4

-6%

Alexza Pharmaceuticals Inc. (ALXA) (IPO; co-lead)

3/8/06

$8

$11.39

$50.6

+42%

Alnylam Pharmaceuticals Inc. (ALNY)

1/31/06

$13

$21.40

$66.5

+65%

Arena Pharmaceuticals Inc. (ARNA)

1/27/06

$16.90

$12.91

$179.8

-24%

Arena Pharmaceuticals Inc. (ARNA) (co-lead)

12/8/06

$13.21

$12.91

$174.7

-2%

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Exelixis Inc. (EXEL)

10/5/06

$8.40

$9

$96.6

+7%

Metabolix Inc. (MBLX) (IPO; lead)

11/17/06

$14

$18.94

$109.5

+35%

Sangamo BioSciences Inc. (SGMO) (lead)

6/15/06

$6.50

$6.60

$20.2

+2%

SGX Pharmaceuticals Inc. (SGXP) (IPO; co-lead)

1/31/06

$6

$3.50

$24.9

-42%

Punk, Ziegel & Co.

Genitope Corp. (GTOP)

2/7/06

$8.50

$3.52

$62.6

-59%

RBC Capital Markets

Affymax Inc. (AFFY) (IPO)

12/15/06

$25

$34.04

$106.4

+36%

Alexza Pharmaceuticals Inc. (ALXA) (IPO)

3/8/06

$8

$11.39

$50.6

+42%

RBC Capital Markets

Genitope Corp. (GTOP) (co-lead)

2/7/06

$8.50

$3.52

$62.6

-59%

Pharmacyclics Inc. (PCYC) (co-lead)

11/7/06

$4.75

$5.07

$22.9

+7%

Robert W. Baird & Co.

Cepheid Inc. (CPHD)

3/8/06

$8.60

$8.50

$86

-1%

Cerus Corp. (CERS) (co-lead)

3/16/06

$8.75

$5.86

$45.3

-33%

Illumina Inc. (ILMN)

5/19/06

$25.50

$39.31

$102.6

+54%

Rodman & Renshaw

Alnylam Pharmaceuticals Inc. (ALNY)

1/31/06

$13

$21.40

$66.5

+65%

BioMarin Pharmaceutical Inc. (BMRN)

3/24/06

$13

$16.39

$134.6

+26%

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Omrix Bio-pharmaceuticals Inc. (OMRI)

12/15/06

$32

$30.26

$48

-5%

Roth Capital Partners

Cleveland BioLabs Inc. (CBLI) (IPO; co-lead)

7/20/06

$6

$5.04

$10.2

-16%

Stifel Nicolaus

Catalyst Pharmaceutical Partners Inc. (CPRX) (IPO; co-lead)

11/9/06

$6

$4.83

$20.1

-20%

Sunrise Securities

Cleveland BioLabs Inc. (CBLI) (IPO; co-lead)

7/20/06

$6

$5.04

$10.2

-16%

Susquehanna Financial

Iomai Corp. (IOMI) (IPO)

2/1/06

$7

$4.98

$35

-29%

ThinkEquity
Partners

Advanced Magnetics Inc. (AMAG) (lead)

3/6/06

$27.46

$59.72

$33.8

+117%

Advanced Magnetics Inc. (AMAG)

12/7/06

$62

$59.72

$130.4

-4%

Thomas Weisel Partners

Affymax Inc. (AFFY) (IPO)

12/15/06

$25

$34.04

$106.4

+36%

Celgene Corp. (CELG)

11/3/06

$51.60

$57.53

$1,032

+11%

Metabolix Inc. (MBLX) (IPO)

11/17/06

$14

$18.94

$109.5

+35%

Pharmacyclics Inc. (PCYC) (co-lead)

11/7/06

$4.75

$5.07

$22.9

+7%

Theravance Inc. (THRX)

2/1/06

$28.50

$30.89

$131.1

+8%

Vanda Pharmaceuticals Inc. (VNDA) (IPO)

4/12/06

$10

$24.65

$59.6

+147%

UBS Investment Bank

Advanced Magnetics Inc. (AMAG) (co-lead)

12/7/06

$62

$59.72

$130.4

-4%

Arena Pharmaceuticals Inc. (ARNA) (co-lead)

1/27/06

$16.90

$12.91

$179.8

-24%

Cepheid Inc. (CPHD) (lead)

3/8/06

$8.60

$8.50

$86

-1%

Iomai Corp. (IOMI) (IPO; co-lead)

2/1/06

$7

$4.98

$35

-29%

Indevus Pharmaceuticals Inc. (IDEV) (lead)

6/28/06

$4.65

$7.10

$37.43

+53%

NeoPharm Inc. (NEOL) (lead)

1/5/06

$10.20

$1.67

$41.1

-84%

Omrix Bio\pharmaceuticals Inc. (OMRI) (IPO; co-lead)

4/20/06

$10

$30.26

$39.6

+203%

Omrix Biopharmaceuticals Inc. (OMRI) (co-lead)

12/15/06

$32

$30.26

$48

-5%

Sirna Therapeutics Inc. (RNAI) (co-lead)

5/24/06

$5

$13**

$51.8

+160%

UBS Investment
Bank

Valera Pharmaceuticals Inc. (VLRX) (IPO; co-lead)

2/2/06

$9

$8.10

$34.8

-10%

Vertex Pharmaceuticals Inc. (VRTX)

9/14/06

$33

$37.42

$300.3

+13%

Wachovia Capital Markets

MannKind Corp. (MNKD)

12/7/06

$17.42

$16.49

$400.7

-5%

Westwind Partners

Labopharm Inc. (Canada; DDSS)

4/28/06

$8

$5.87

$101.2

-27%

William Blair & Co.

Cepheid Inc. (CPHD)

3/8/06

$8.60

$8.50

$86

-1%

WR Hambrecht + Co.

Genitope Corp. (GTOP) (co-lead)

2/7/06

$8.50

$3.52

$62.6

-59%


Notes:
* The financings in this chart include only public offerings of stock in the U.S. The data were compiled primarily from BioWorld Financial Watch's monthly financing charts covering the period from Jan. 1 to Dec. 31, 2006. The gross proceed totals include money raised through overallotment options. Offering prices were adjusted to reflect stock splits, where applicable. The issue next week will evaluate underwriters' performance.
** Sirna Therapeutics Inc. was acquired for $13 per share on Dec. 29, 2006.
Unless otherwise noted, shares are traded on the Nasdaq exchange.
AMEX = American Stock Exchange; NYSE = New York Stock Exchange.